Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201110053 Principal Investigator: Carson, Kenneth
Title: A Phase II Study of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating with Pralatrexate (P) as Front Line Therapy for Patients with Stage II, III and IV Peripheral T-Cell Non-Hodgkin’s Lymphoma
Phase: II Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
This study is being done to test the safety of pralatrexate when given alternately with Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) as front line therapy. The study will see what effects this regimen has when given to patients with Stage II, III and IV PTCL.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)